Acupoint Thermal Radiation Characteristics in Adolescents with MDD
1 other identifier
observational
100
1 country
1
Brief Summary
Modern studies have confirmed that skin temperature changes at acupoints when the body is under pathological conditions. This suggests that changes in the thermal radiation characteristics of acupoints can objectively respond to the symptoms of a disease. In this study, the investigators first evaluated reproducibility of acupoint temperature measurement by IRT. Secondly, the investigators explored the thermal radiation characteristics of MDD-related acupoints, built the diagnostic model for adolescent depression severity and the diagnostic model for MDD in adolescents based on acupoint temperature. Our research findings will provide new ideas, methods and visualisations for early screening, auxiliary diagnosis and condition assessment of MDD in adolescents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
December 20, 2024
CompletedFirst Posted
Study publicly available on registry
December 27, 2024
CompletedDecember 31, 2024
December 1, 2024
2.3 years
December 20, 2024
December 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acupoint emperature
Temperature of acupoints was measured by infrared thermography (IRT). IRT was not be performed on female subjects during their menstrual and ovulatory periods.
Baseline
Secondary Outcomes (1)
The Self-Rating Depression Scale (SDS) Scores
Baseline
Study Arms (2)
Healthy Control group
There were 40 healthy control participants in the Healthy Control group.
Major Depression Disorder group
There were 60 MDD patients in the MDD group. All MDD adolescents received at least one IRT test. 26 MDD adolescents were detected by 2 investigators and 2 investigators both made 2 independent measurements in a week. 30 MDD subjects were detected the bilateral same name acupoint temperatures.
Interventions
A thermograph (NEC InfRec R450, Avio Infrared Technologies Co., Ltd., Tokyo) was used to record thermal images. The infrared camera was fixed on a tripod 1 m away from the subject to ensure that no shaking movements or vibrations occurred during the recording of thermal images. MDD related acupoints on the inner and outer sides of the limbs were detected. Appropriate body position was selected according to the different parts to be detected. Using the automatic interval saving shooting mode, one thermal picture was taken at 10-s intervals, 3 pictures were taken for each subject.
Eligibility Criteria
The diagnostic criteria of MDD were based on criteria proposed by the International Classification of Diseases 10th Edition (ICD-10). Healthy control participants were determined by a recent depression screening report for confirming their mental health conditions.
You may qualify if:
- years≤ age\<18 years;
- SDS score \<53;
- Adolescents with normal cognitive function can cooperate with the study;
- Adolescents and guardians agree to the study plan and sign the informed consent form.
- years≤ age\<18 years;
- Self-rating Depression Scale (SDS) score ≥ 53;
- Language, cognition and communication ability are normal;
- Patients and guardians agree to the study plan and sign the informed consent form.
You may not qualify if:
- Severe anxiety, schizophrenia, or other serious mental illnesses;
- There are pigmentation, redness, infection or scarring on the skin at the site of detection;
- Patients with severe systemic diseases and their complications, serious infections, and major diseases of viscera, tissues, and systems;
- Female patients who were pregnant or lactating;
- Female patients who were during, or in proximity (±2 days) to their menstruation or ovulation;
- Patients with a body temperature ≥37.3°C;
- Inability to cooperate during the examination;
- Participating in any other clinical trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xiaomei Shaolead
- Zhejiang Provincial Tongde Hospitalcollaborator
- First People's Hospital of Hangzhoucollaborator
Study Sites (1)
the Third affiliated hospital of Zhejiang Chinese Medical university
Hangzhou, Zhejiang, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
December 20, 2024
First Posted
December 27, 2024
Study Start
March 5, 2022
Primary Completion
June 30, 2024
Study Completion
November 30, 2024
Last Updated
December 31, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share